AVTX Competitors & Alternatives
Compare Avalo Therapeutics Inc with similar stocks in the same industry
Biotechnology
AVTX
Main Stock$16.18
Tradestie Score
49
Market Cap
$170.45M
Revenue Growth
-0.7%
Analyst Upside
+172.5%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANAB
AnaptysBio, Inc. Common Stock
|
$54.11
|
$894.30M | - | 43 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$24.54
|
$887.30M | - | 58 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$5.13
|
$879.90M | 6.5 | 42 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.68
|
$871.90M | - | 54 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.01
|
$867.49M | - | 46 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$17.41
|
$864.42M | - | 54 | Compare |
|
CRMD
CorMedix Inc.
|
$7.89
|
$862.55M | 3.6 | 39 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$39.55
|
$847.12M | - | 62 | Compare |
|
XNCR
Xencor, Inc.
|
$24.53
|
$843.75M | - | 37 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$27.89
|
$841.74M | - | 51 | Compare |
More AVTX Analysis
Data updated: Sep 15, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry